Meeting
2022 ASCO Annual Meeting
Extracellular vesicle-based biomarker assay for the detection of early-stage ovarian cancer.
Authors
Laura Bortolin
Mercy BioAnalytics, Inc., Natick, MA
Laura Bortolin , Daniel P. Salem , Jonian Grosha , Ibukunoluwapo O. Zabroski , Sanchari Banerjee , Daniel Gusenleitner , Kelly M. Biette , Christopher R. Sedlak , Anthony D. Couvillon , Peter A. Duff , Delaney M. Byrne , MacKenzie Sadie King , Amy Jamieson , Emily S. Winn-Deen , Jessica N. McAlpine , David Huntsman , Steven Skates , Eric K. Huang , Joseph Charles Sedlak
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5542)
DOI
10.1200/JCO.2022.40.16_suppl.5542
Abstract #
5542
Poster Bd #
421
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Evaluation of a novel extracellular vesicle (EV) based ovarian cancer (OC) screening test in asymptomatic postmenopausal women.
First Author: Brendan Manning
Poster
2011 ASCO Annual Meeting
A multivariate longitudinal algorithm for early detection of ovarian cancer using multiple biomarkers.
First Author: Z. Zhang
Poster
2023 ASCO Annual Meeting
The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update.
First Author: Chae Young Han
Poster
2023 ASCO Annual Meeting
ExoLuminate: An observational registry study for detection of pancreatic adenocarcinoma (PDAC) in high-risk or clinically suspicious patients.
First Author: Harmeet Dhani